Method for manufacturing tertiary amino group-containing lipid

US9371271B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9371271-B2
Application numberUS-201314412546-A
CountryUS
Kind codeB2
Filing dateJun 21, 2013
Priority dateJul 2, 2012
Publication dateJun 21, 2016
Grant dateJun 21, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

In production of a cationic lipid having at least one methylene group sandwiched between adjacent two cis form double bonds in the molecule, isomerization from a cis form to a trans form is suppressed. A compound represented by the following formula (I): R 1 —X  (I) (in Formula, R 1 represents a hydrocarbon group having at least one methylene group sandwiched between adjacent two cis form double bonds in the molecule and having the carbon number of 8 to 24 and X represents a releasing group) is reacted with (B) a compound having at least one of each of tertiary amino group and hydroxyl group in the molecule in a saturated hydrocarbon solvent having the carbon number of 5 to 10 in the presence of an alkali catalyst.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for manufacturing a tertiary amino group-containing lipid, comprising: reacting (A) a compound represented by Formula (I) described below R 1 −X  ( 1 ) in Formula, R 1 represents a hydrocarbon group having at least one methylene group sandwiched between adjacent two cis form double bonds in the molecule and having the carbon number of 8 to 24 and X represents a functional group which is released by reaction with a hydroxyl group in the compound having at least one of each of tertiary amino groups and hydroxyl group, so as to form an ether bond and (B) a compound having at least one of each of tertiary amino group and hydroxyl group in the molecule in a saturated hydrocarbon solvent having a carbon number of 5 to 10 in the presence of an alkali catalyst, wherein the compound having at least one of each of tertiary amino group and hydroxyl group in the molecule of the item (B) is selected from the compound represented by Formula (II-1) described below in Formula, Z represents a divalent to octavalent hydrocarbon group having the carbon number of 1 to 8,which may be in a straight chain, branched, or cyclic shape, k 1 satisfies 1 ≦k 1 ≦7,k 2 satisfies 1 ≦k 2 ≦3, 2≦k 1 +k 2 ≦8 is satisfied, and Y is one of functional groups represented by the following structures, R 2 and R 3 represent independently a straight chain, branched, or cyclic hydrocarbon group having the carbon number of 1 to 8, and W represents O or NR 4 ; R 4 represents an alkyl group having the carbon number of 1 to 3 and the compound represented by Formula (II-2) described below in Formula, m represents 1 to 4,R 5 represents a straight chain or branched alkyl group having the carbon number of 1 to 4 or—(CH 2 ) n —OH; and n represents 1 to 4. 2. The method according to claim 1 , wherein the saturated hydrocarbon solvent is hexane or methylcyclohexane. 3. The method according to claim 1 , wherein R 1 is a linoleyl group. 4. The method according to claim 2 , wherein R 1 is a linoleyl group. 5. The method according to claim 1 , wherein X is a methane sulfonate group (—OSO 2 CH 3 ). 6. The method according to claim 2 , wherein X is a methane sulfonate group (—OSO 2 CH 3 ). 7. The method according to claim 3 , wherein X is a methane sulfonate group (—OSO 2 CH 3 ). 8. The method according to claim 4 , wherein X is a methane sulfonate group (—OSO 2 CH 3 ). 9. The method according to claim 1 , wherein the alkali catalyst is potassium hydroxide. 10. The method according to claim 2 , wherein the alkali catalyst is potassium hydroxide. 11. The method according to claim 3 , wherein the alkali catalyst is potassium hydroxide. 12. The method according to claim 4 , wherein the alkali catalyst is potassium hydroxide.

Assignees

Inventors

Classifications

  • C07C213/06Primary

    from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups · CPC title

  • having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines · CPC title

  • substituted by singly bound oxygen or sulfur atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9371271B2 cover?
In production of a cationic lipid having at least one methylene group sandwiched between adjacent two cis form double bonds in the molecule, isomerization from a cis form to a trans form is suppressed. A compound represented by the following formula (I): R 1 —X  (I) (in Formula, R 1 represents a hydrocarbon group having at least one methylene group sandwiched between adjacent two cis…
Who is the assignee on this patent?
Nof Corp
What technology area does this patent fall under?
Primary CPC classification C07C213/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).